Mineralys Therapeutics, Inc.盘中异动股价大跌5.02%报14.20美元

市场透视11-07

北京时间2024年11月07日23时20分，Mineralys Therapeutics, Inc.（MLYS.us）股票出现异动，股价大幅下跌5.02%。截至发稿，该股报14.20美元/股，成交量5.4514万股，换手率0.11%，振幅5.55%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-41.01百万美元，每股收益-0.83美元，毛利-9000.00美元，市盈率-5.14倍。...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2481182117?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-11-07 23:20","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2481182117","market":"us","top_or_hot":-1,"title":"Mineralys Therapeutics, Inc.盘中异动 股价大跌5.02%报14.20美元","media":"市场透视","content":"<div>\n<p>北京时间2024年11月07日23时20分，Mineralys Therapeutics, Inc.（MLYS.us）股票出现异动，股价大幅下跌5.02%。截至发稿，该股报14.20美元/股，成交量5.4514万股，换手率0.11%，振幅5.55%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-41.01百万美元，每股收益-0.83美元，毛利-9000.00美元，市盈率-5.14倍。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107232044abaa8ea5&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Mineralys Therapeutics, Inc.盘中异动 股价大跌5.02%报14.20美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMineralys Therapeutics, Inc.盘中异动 股价大跌5.02%报14.20美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-07 23:20 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107232044abaa8ea5&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年11月07日23时20分，Mineralys Therapeutics, Inc.（MLYS.us）股票出现异动，股价大幅下跌5.02%。截至发稿，该股报14.20美元/股，成交量5.4514万股，换手率0.11%，振幅5.55%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-41.01百万美元，每股收益-0.83美元，毛利-9000.00美元，市盈率-5.14倍。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107232044abaa8ea5&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LENZ","symbol_name":"Therapeutics","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107232044abaa8ea5&s=b","article_id":"2481182117","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107232044abaa8ea5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2481182117","pubTimestamp":1730992843,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年11月07日23时20分，Mineralys Therapeutics, Inc.股票出现异动，股价大幅下跌5.02%。Mineralys Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Ensysce Biosciences, Inc.、Celularity Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025涨幅较大，Ensysce Biosciences, Inc.、Elevai Labs, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为642.64%、128.04%、91.74%，振幅较大的相关个股有180 Life Sciences Corp C/Wts 07/11/2025、Celularity Inc.、Ensysce Biosciences, Inc.，振幅分别为68.89%、59.31%、57.79%。Mineralys Therapeutics, Inc.公司简介：Mineralys Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发药物以治疗醛固酮异常升高引起的疾病。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LENZ":"Therapeutics","MLYS":"Mineralys Therapeutics, Inc.","BK4139":"生物科技"},"translate_title":"Mineralys Therapeutics, Inc. shares fell 5.02% to $14.20 after intraday changes","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LENZ":1,"MLYS":1},"content_text":"北京时间2024年11月07日23时20分，Mineralys Therapeutics, Inc.（MLYS.us）股票出现异动，股价大幅下跌5.02%。截至发稿，该股报14.20美元/股，成交量5.4514万股，换手率0.11%，振幅5.55%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-41.01百万美元，每股收益-0.83美元，毛利-9000.00美元，市盈率-5.14倍。机构评级方面，在所有7家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Mineralys Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Ensysce Biosciences, Inc.、Celularity Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025(To Pur Com)涨幅较大，Ensysce Biosciences, Inc.、Elevai Labs, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为642.64%、128.04%、91.74%，振幅较大的相关个股有180 Life Sciences Corp C/Wts 07/11/2025(To Pur Com)、Celularity Inc.、Ensysce Biosciences, Inc.，振幅分别为68.89%、59.31%、57.79%。Mineralys Therapeutics, Inc.公司简介：Mineralys Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发药物以治疗醛固酮异常升高引起的疾病。 该公司的候选产品lorundrostat是一种专有的口服选择性醛固酮合成酶抑制剂，最初开发用于治疗未控制的高血压患者，定义为服用两种或两种以上抗高血压药物或顽固性高血压仍无法将血压降至130/80 mmHg以下的患者。定义为尽管服用了三种或更多种抗高血压药物(通常包括利尿剂)，但仍无法将血压控制在130/80 mmHg以下的个体。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2481182117"}

Mineralys Therapeutics, Inc.盘中异动 股价大跌5.02%报14.20美元

精彩评论

Mineralys Therapeutics, Inc.盘中异动股价大跌5.02%报14.20美元